These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30675956)

  • 1. Factors affecting breast cancer patients' need for genetic risk information: From information insufficiency to information need.
    Hong SJ; Biesecker B; Ivanovich J; Goodman M; Kaphingst KA
    J Genet Couns; 2019 Jun; 28(3):543-557. PubMed ID: 30675956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worry as an Uncertainty-Associated Emotion: Exploring the Role of Worry in Health Information Seeking.
    Lee SY; Hawkins RP
    Health Commun; 2016 Aug; 31(8):926-33. PubMed ID: 26752071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors.
    Kaphingst KA; Ivanovich J; Lyons S; Biesecker B; Dresser R; Elrick A; Matsen C; Goodman M
    Transl Behav Med; 2018 Jan; 8(1):71-79. PubMed ID: 29385583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk, efficacy, and seeking of general, breast, and prostate cancer information.
    Nan X; Underhill J; Jiang H; Shen H; Kuch B
    J Health Commun; 2012; 17(2):199-211. PubMed ID: 22026448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial and Clinical Factors Associated with Family Communication of Cancer Genetic Test Results among Women Diagnosed with Breast Cancer at a Young Age.
    Elrick A; Ashida S; Ivanovich J; Lyons S; Biesecker BB; Goodman MS; Kaphingst KA
    J Genet Couns; 2017 Feb; 26(1):173-181. PubMed ID: 27422778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of cancer worry in unaffected women from high risk breast cancer families: risk perception is not the primary issue.
    Price MA; Butow PN; Lo SK; Wilson J;
    J Genet Couns; 2007 Oct; 16(5):635-44. PubMed ID: 17828585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk.
    Dean M
    Soc Sci Med; 2016 Aug; 163():21-7. PubMed ID: 27376595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
    Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in-depth exploration of information-seeking behavior among individuals with cancer: part 1: understanding differential patterns of active information seeking.
    Lambert SD; Loiselle CG; Macdonald ME
    Cancer Nurs; 2009; 32(1):11-23; quiz 24-5. PubMed ID: 19104197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in-depth exploration of information-seeking behavior among individuals with cancer: part 2: understanding patterns of information disinterest and avoidance.
    Lambert SD; Loiselle CG; Macdonald ME
    Cancer Nurs; 2009; 32(1):26-36. PubMed ID: 19104199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of worry after breast cancer risk assessment: 6-year follow-up of the TRACE study cohort.
    Brain K; Parsons E; Bennett P; Cannings-John R; Hood K
    Psychooncology; 2011 Sep; 20(9):984-91. PubMed ID: 20677331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
    Dean M; Davidson LG
    Health Commun; 2018 Feb; 33(2):122-130. PubMed ID: 27976925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining information-seeking behavior in genetic testing for cancer predisposition: A qualitative interview study.
    Zimmermann BM; Fanderl J; Koné I; Rabaglio M; Bürki N; Shaw D; Elger B
    Patient Educ Couns; 2021 Feb; 104(2):257-264. PubMed ID: 32988685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive decision-making in young female carriers of a BRCA mutation.
    Donnelly LS; Watson M; Moynihan C; Bancroft E; Evans DG; Eeles R; Lavery S; Ormondroyd E
    Hum Reprod; 2013 Apr; 28(4):1006-12. PubMed ID: 23293217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy.
    Hanoch Y; Miron-Shatz T; Rolison JJ; Ozanne E
    Psychooncology; 2014 Oct; 23(10):1142-8. PubMed ID: 24733657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
    Moran O; Nikitina D; Royer R; Poll A; Metcalfe K; Narod SA; Akbari MR; Kotsopoulos J
    Breast Cancer Res Treat; 2017 Jan; 161(1):135-142. PubMed ID: 27798748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.